Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2005
10/06/2005US20050220873 Pharmaceutical dosage forms having immediate and controlled release properties that contain a GABAB receptor agonist
10/06/2005US20050220872 Release control type formed product
10/06/2005US20050220871 Taste masking granules
10/06/2005US20050220870 administering mixtures of proton pump inhibitors and buffers, used for prophylaxis of gastrointestinal disorders
10/06/2005US20050220869 Particulate compositions
10/06/2005US20050220868 Policosanol composition and its use in treatment of hypercholesterolemia
10/06/2005US20050220866 Novel capsule formulations of etoposide for oral use
10/06/2005US20050220865 Compressed composition comprising magnesium salt
10/06/2005US20050220864 Pharmaceutical dosage forms having controlled release properties that contain a GABAB receptor agonist
10/06/2005US20050220863 Pharmaceutical dosage forms having controlled release properties that contain a GABAB receptor agonist
10/06/2005US20050220862 Compositions with reduced hepatotoxicity
10/06/2005US20050220861 Colonic release compostion
10/06/2005US20050220859 Methods for treating illnesses of the tracheo-bronchial tract, especially chronic obstructive pulmonary disease (COPD)
10/06/2005US20050220858 Codelivery to a cell of nucleic acid and assistor protein (antigen) where the nucleic acid encodes an antigenic protein or which shares an epitope(s) with the assistor protein; the nucleic acid is entrapped in liposome intravesicular space; assistor protein is on the liposome surface; synergistic
10/06/2005US20050220857 Physiologically compatible, phospholipid-containing, stable and hard matrix
10/06/2005US20050220856 Phospholipid derivative
10/06/2005US20050220855 Matrix for administering ergoline compounds such as lisuride; restless leg syndrome; circadian rhythm disorders; Parkinson's disease
10/06/2005US20050220854 Apparatus and method for transdermal delivery of influenza vaccine
10/06/2005US20050220853 Controlled delivery of therapeutic agents from medical articles
10/06/2005US20050220852 Adhesive patch containing tulobuterol
10/06/2005US20050220851 Matrix type patch containing bronchodilators
10/06/2005US20050220850 Topical anhydrous and ethanol-free ascomycin compositions
10/06/2005US20050220848 Graft material, stent graft and method
10/06/2005US20050220843 a blends comprising ethylene-vinyl acetate copolymer and poly(alkyl(meth)acrylates or poly(aromatic(meth)acrylates); implantable medical device; permit stents releasing the bioactive agent over time in vivo; provide clear coats, durability, biocompatibility, and release kinetics; drug delivery device
10/06/2005US20050220842 Coating compositions for bioactive agents
10/06/2005US20050220841 Coating compositions for bioactive agents
10/06/2005US20050220840 Coating compositions for bioactive agents
10/06/2005US20050220839 Coating compositions for bioactive agents
10/06/2005US20050220831 Poloxamer emulsion preparations
10/06/2005US20050220825 Molecular dispersions of drospirenone
10/06/2005US20050220824 compacted powder slug encapsulated with a film; Tablets; tamper evident capsules
10/06/2005US20050220823 Ophthalmic composition comprising ascomycin
10/06/2005US20050220819 Novel binding epitopes for helicobacter pylori and use thereof
10/06/2005US20050220805 Polynucleotide sequence for Chalmydia pneumonia; therapy, prevention of Chlamydia infections ; vaccines
10/06/2005US20050220786 Lyophilised preparation comprising antibodies against the efg receptor
10/06/2005US20050220780 Pharmaceutical composition having thrombolytic anti-inflammatory and cytoprotective properties
10/06/2005US20050220768 Materials and methods for treating ocular-related disorders
10/06/2005US20050220767 Production of recombinant respiratory syncytial viruses expressing immune modulatory molecules
10/06/2005US20050220763 Method of treating idiopathic pulmonary fibrosis with aerosolized IFN-gamma
10/06/2005US20050220758 Lyophilised preparation comprising immunocytokines
10/06/2005US20050220755 Topical composition based on ion-exchange resins, in particular for treating erythemas
10/06/2005US20050220752 removing potassium from the gastrointestinal tract with a potassium-binding polymer; an alpha-fluoroacrylic acid polymer, or a difluoromaleic acid polymer crosslinked with vinylsulfonic acid, acrylic acid, vinyl phosphonate, vinyl-1,1-bisphosphonate, vinyl sulfonate, vinyl-1,2-disulfonate, itaconic aci
10/06/2005US20050220723 Aerosol device comprising a propellant and a styling composition comprising, in a predominantly aqueous medium, a pseudo-block polymer and an additional fixing polymer; processes therefor and uses thereof
10/06/2005US20050220722 Method of decreasing fasting sugars and weight gains in diabetic patients
10/06/2005US20050220721 Anti-adhesion spraying
10/06/2005US20050220720 Formulations limiting spread of pulmonary infections
10/06/2005US20050220718 Stable pharmaceutical solution formulations for pressurized metered dose inhalers
10/06/2005US20050220717 Steroid solution aerosol products with enhanced chemical stability
10/06/2005US20050220716 Drug delivery assembly
10/06/2005US20050220715 Methods and compositions for improving drug safety
10/06/2005US20050218076 Process for the formation of particulate material
10/06/2005CA2560919A1 Uses of anti-ctla-4 antibodies
10/06/2005CA2560900A1 Nanoparticle formulations of platinum compounds
10/06/2005CA2560241A1 Carbohydrate-derivatized liposomes for targeting cellular carbohydrate recognition domains of ctl/ctld lectins, and intracellular delivery of therapeutically active compounds
10/06/2005CA2559753A1 Bioavailable nutritional supplement and method of treatment of malabsorption
10/06/2005CA2559735A1 Biopolymer compositions and products thereof
10/06/2005CA2559685A1 Gastroresistant pharmaceutical dosage form comprising n-(2-(2-phthalimidoethoxy)-acetyl)-l-alanyl-d-glutamic acid (lk-423)
10/06/2005CA2559050A1 Multilayered transdermal drug delivery device
10/06/2005CA2559029A1 Complex particles and coated complex particles
10/06/2005CA2558884A1 Anhydrous pharmaceutical composition associating a siliconated agent and solubilised active principle
10/06/2005CA2558787A1 Oral matrix formulations comprising licarbazepine
10/06/2005CA2558785A1 Drug-enhanced adhesion prevention
10/06/2005CA2558535A1 A stable pharmaceutical composition comprising an acid labile drug
10/06/2005CA2558513A1 Amorolfine patch for treating onychomycosis
10/06/2005CA2558307A1 Disintegrating tablets comprising licarbazepine
10/06/2005CA2557783A1 Film compositions
10/06/2005CA2557718A1 Film products having controlled disintegration properties
10/06/2005CA2556443A1 Dry powder preparations for pre-metered dpi
10/06/2005CA2554860A1 Pharmaceutical composition and method for the transdermal delivery of magnesium
10/05/2005EP1582222A1 Surface-active agents in powder form for use in tablets and capsules, their process of manufacture and compositions containing them
10/05/2005EP1582221A1 Pharmaceutical oral compositions with a taste masking effect
10/05/2005EP1582212A1 Intravitreally-injectable solution for the treatment of vitreous haemorrhages
10/05/2005EP1582210A2 Compositions and methods for treating or preventing surgical adhesions
10/05/2005EP1582206A1 Water-soluble composition containing coenzyme q10
10/05/2005EP1582205A2 Agglomerated hydrophilic complexes with multi-phasic release characteristics
10/05/2005EP1582204A2 Echinocandin pharmaceutical formulations containing micelle-forming surfactants
10/05/2005EP1582196A2 Translucent nanoemulsion, production method, and uses thereof in the cosmetic, dermatological and/or ophthalmological fields.
10/05/2005EP1582192A1 A method and dosage form for dispensing a bioactive substance
10/05/2005EP1582191A1 A method and dosage form for dispensing a bioactive substance
10/05/2005EP1582186A1 Condom coated with lactobacillus compositions
10/05/2005EP1582105A1 Method of inhibiting water content variation of composition and use thereof
10/05/2005EP1581640A2 Encapsulated cells for therapy
10/05/2005EP1581639A2 High pressure spray-dry of bioactive materials
10/05/2005EP1581583A1 Multi-arm polypeptide-poly(ethylene glycol) block copolymers as drug delivery vehicles
10/05/2005EP1581301A2 Active agent delivery device having composite members
10/05/2005EP1581287A1 Multiple infusion section catheters, systems, and methods
10/05/2005EP1581286A1 Permeable membrane catheters, systems, and methods
10/05/2005EP1581285A1 Drug solution density adjustment systems and methods
10/05/2005EP1581284A1 Implantable drug delivery systems and methods
10/05/2005EP1581274A1 Injectable gel-forming compositions based on cross-linked and non-cross-linked polymers and the use thereof
10/05/2005EP1581259A1 Method and material for specific proliferation promotion of lymphocyte sub-populations by means of a combination of an immunomodulator with a non-water-soluble natural product and a carrier
10/05/2005EP1581258A1 Pharmaceutical formulation and a method of making same
10/05/2005EP1581255A1 An acqueous pharmaceutical formulation comprising the thrombin inhibitor melagatran and use of the formulation in the manufacture of a medicament for use by nasal administration in treating thromboembolism
10/05/2005EP1581250A2 Oral formulations for proteins and polypeptides
10/05/2005EP1581245A2 Compositions and methods for enhanced mucosal delivery of y2 receptor-binding peptides and methods for treating and preventing obesity
10/05/2005EP1581236A2 Sustained release of antiinfectives
10/05/2005EP1581230A2 Method and compositions for treating anxiety
10/05/2005EP1581211A1 Contact lens and eye drop rewetter compositions and their uses
10/05/2005EP1581210A1 Dosage forms comprising a cetp inhibitor and an hmg-coa reductase inhibitor
10/05/2005EP1581201A1 Method for producing sterile polynucleotide based medicaments
1 ... 1743 1744 1745 1746 1747 1748 1749 1750 1751 1752 1753 1754 1755 1756 1757 1758 1759 1760 1761 1762 1763 ... 2991